Preparing the Country for the Alzheimer’s Epidemic: A View from Science, Business, Government, and Caregivers
Part 3: A View from Business
Date: November 14, 2006
Location: Washington, DC
Robert Essner, CEO and Chairman, Wyeth Pharmaceuticals discussed the dimensions and depth of the Alzheimer’s crisis, including why aggressive action is needed immediately. He discussed how Wyeth decided to respond to this challenge, with aggressive investments in research and development. watch video >>
